Terms: = Astrocytoma AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53
2188 results:
1. MELATONIN ENHANCES TEMOZOLOMIDE-INDUCED APOPTOSIS IN GLIOBLASTOMA AND NEUROBLASTOMA CELLS.
Bostanci A; Doganlar O
Exp Oncol; 2024 Oct; 46(2):87-100. PubMed ID: 39396175
[TBL] [Abstract] [Full Text] [Related]
2. Autophagy-associated biomarkers ULK2, UVRAG, and miRNAs miR-21, miR-126, and miR-374: Prognostic significance in glioma patients.
Amin W; Enam SA; Sufiyan S; Ghias K; Bajwa MH; Ilyas S; Laghari AA; Naeem S; Abidi SH; Mughal N
PLoS One; 2024; 19(9):e0311308. PubMed ID: 39348350
[TBL] [Abstract] [Full Text] [Related]
3.
Jana S; Mondal M; Mahale S; Gupta B; Prasasvi KR; Kandasami L; Jha N; Chowdhury A; Santosh V; Kanduri C; Somasundaram K
Elife; 2024 Sep; 12():. PubMed ID: 39302097
[TBL] [Abstract] [Full Text] [Related]
4. Cost-effective optimized method to process 3D tumoral spheroids in microwell arrays for immunohistochemistry analysis.
Matei MB; Marinescu CL; Matei CO; Pînzariu AS; Zăgrean L; Moisescu MG
J Med Life; 2024 Jun; 17(6):601-609. PubMed ID: 39296442
[TBL] [Abstract] [Full Text] [Related]
5. [Clinicopathological and molecular characteristics of pediatric gliomas: analysis of 111 cases].
Xu H; Niu HL; Wang FH; Xu XK; Wang W; Yuan L; Chen K; Gao Q; Li LP; Xia JQ; Guo ZM
Zhonghua Bing Li Xue Za Zhi; 2024 Sep; 53(9):922-928. PubMed ID: 39231745
[No Abstract] [Full Text] [Related]
6. Chromosomal instability: a key driver in glioma pathogenesis and progression.
Mazzoleni A; Awuah WA; Sanker V; Bharadwaj HR; Aderinto N; Tan JK; Huang HYR; Poornaselvan J; Shah MH; Atallah O; Tawfik A; Elmanzalawi MEAE; Ghozlan SH; Abdul-Rahman T; Moyondafoluwa JA; Alexiou A; Papadakis M
Eur J Med Res; 2024 Sep; 29(1):451. PubMed ID: 39227895
[TBL] [Abstract] [Full Text] [Related]
7. Comparative genomic landscape of lower-grade glioma and glioblastoma.
Sun X; Jia Q; Li K; Tian C; Yi L; Yan L; Zheng J; Jia X; Gu M
PLoS One; 2024; 19(8):e0309536. PubMed ID: 39208202
[TBL] [Abstract] [Full Text] [Related]
8. IGF2BP3 promotes mRNA degradation through internal m
Liu C; Dou X; Zhao Y; Zhang L; Zhang L; Dai Q; Liu J; Wu T; Xiao Y; He C
Nat Commun; 2024 Aug; 15(1):7421. PubMed ID: 39198433
[TBL] [Abstract] [Full Text] [Related]
9. A cell state-specific metabolic vulnerability to GPX4-dependent ferroptosis in glioblastoma.
Banu MA; Dovas A; Argenziano MG; Zhao W; Sperring CP; Cuervo Grajal H; Liu Z; Higgins DM; Amini M; Pereira B; Ye LF; Mahajan A; Humala N; Furnari JL; Upadhyayula PS; Zandkarimi F; Nguyen TT; Teasley D; Wu PB; Hai L; Karan C; Dowdy T; Razavilar A; Siegelin MD; Kitajewski J; Larion M; Bruce JN; Stockwell BR; Sims PA; Canoll P
EMBO J; 2024 Oct; 43(20):4492-4521. PubMed ID: 39192032
[TBL] [Abstract] [Full Text] [Related]
10. tp53 mutations and survival in patients with histologically defined Glioblastoma, IDH-wildtype.
Di Nunno V; Gatto L; Tosoni A; Aprile M; Galvani L; Zappi A; Foschini MP; Asioli S; Tallini G; De Biase D; Maloberti T; Bartolini S; Giannini C; Franceschi E
Pathol Res Pract; 2024 Oct; 262():155516. PubMed ID: 39163733
[TBL] [Abstract] [Full Text] [Related]
11. Glioma lateralization: Focus on the anatomical localization and the distribution of molecular alterations (Review).
Cini NT; Pennisi M; Genc S; Spandidos DA; Falzone L; Mitsias PD; Tsatsakis A; Taghizadehghalehjoughi A
Oncol Rep; 2024 Oct; 52(4):. PubMed ID: 39155859
[TBL] [Abstract] [Full Text] [Related]
12. Design and Synthesis of 7-Oxabicyclo[2.2.1]heptane-2,3-dicarboxylic Acid Derivatives as PP5 Inhibitors To Reverse Temozolomide Resistance in Glioblastoma Multiforme.
Li Z; Guo M; Gu M; Cai Z; Wu Q; Yu J; Tang M; He C; Wang Y; Sun P; You Q; Wang L
J Med Chem; 2024 Sep; 67(17):15691-15710. PubMed ID: 39136241
[TBL] [Abstract] [Full Text] [Related]
13. Assessment of cytotoxic and genotoxic effects of glyphosate-based herbicide on glioblastoma cell lines: Role of p53 in cellular response and network analysis.
Thiel KL; da Silva J; Wolfarth M; Vanini J; Henriques JAP; de Oliveira IM; da Silva FR
Toxicology; 2024 Nov; 508():153902. PubMed ID: 39094917
[TBL] [Abstract] [Full Text] [Related]
14. Genomics and proteomics to determine novel molecular subtypes and predict the response to immunotherapy and the effect of bevacizumab in glioblastoma.
Luo D; Luo A; Hu S; Ye G; Li D; Zhao H; Peng B
Sci Rep; 2024 Jul; 14(1):17630. PubMed ID: 39085480
[TBL] [Abstract] [Full Text] [Related]
15. [Patients with long-term survival in malignant gliomas after photodynamic therapy].
Rynda AY; Olyushin VE; Rostovtsev DM; Kukanov KK; Sklyar SS; Zabrodskaya YM
Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(6):54-61. PubMed ID: 39072567
[TBL] [Abstract] [Full Text] [Related]
16. Enhancing Therapeutic Approaches in Glioblastoma with Pro-Oxidant Treatments and Synergistic Combinations: In Vitro Experience of Doxorubicin and Photodynamic Therapy.
Cesca BA; Caverzan MD; Lamberti MJ; Ibarra LE
Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39062770
[TBL] [Abstract] [Full Text] [Related]
17. Molecular profile and clinical outcome of adult primary spinal cord glioblastoma: a systematic review.
Ezzat B; Young T; Schüpper AJ; Kalagara R; Zhang JY; Lemonick M; Bhanot P; Quinones A; Choudhri T; Germano IM
J Neurosurg Spine; 2024 Oct; 41(4):541-550. PubMed ID: 39059422
[TBL] [Abstract] [Full Text] [Related]
18. A syngeneic spontaneous zebrafish model of
Weiss A; D'Amata C; Pearson BJ; Hayes MN
Elife; 2024 Jul; 13():. PubMed ID: 39052000
[TBL] [Abstract] [Full Text] [Related]
19. Mutations in glioblastoma proteins do not disrupt epitope presentation and recognition, maintaining a specific CD8 T cell immune response potential.
Tarabini RF; Fioravanti Vieira G; Rigo MM; de Souza APD
Sci Rep; 2024 Jul; 14(1):16721. PubMed ID: 39030304
[TBL] [Abstract] [Full Text] [Related]
20. Camouflaging nanoreactor traverse the blood-brain barrier to catalyze redox cascade for synergistic therapy of glioblastoma.
Cheng W; Ren W; Ye P; He L; Bao D; Yue T; Lai J; Wu Y; Wei Y; Wu Z; Piao JG
Biomaterials; 2024 Dec; 311():122702. PubMed ID: 39008916
[TBL] [Abstract] [Full Text] [Related]
[Next]
